CS
ARRY

Credit Suisse’s Array Biopharma Inc ARRY Stock Holding History

Credit Suisse’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,479,960
Closed -$115M – 4368
2019
Q2 		$115M Buy
2,479,960
+1,276,651
+106% +$35.8M 0.1% 189
2019
Q1 		$29.3M Buy
1,203,309
+862,361
+253% +$18M 0.03% 652
2018
Q4 		$4.86M Buy
340,948
+157,250
+86% +$2.39M 0.01% 1604
2018
Q3 		$2.79M Sell
183,698
-68,990
-27% -$1.06M ﹤0.01% 2108
2018
Q2 		$4.24M Buy
252,688
+24,439
+11% +$389K ﹤0.01% 1850
2018
Q1 		$3.73M Buy
228,249
+13,917
+6% +$223K ﹤0.01% 1920
2017
Q4 		$2.74M Sell
214,332
-24,427
-10% -$278K ﹤0.01% 2204
2017
Q3 		$2.94M Sell
238,759
-41,802
-15% -$388K ﹤0.01% 2218
2017
Q2 		$2.35M Sell
280,561
-147,473
-34% -$1.21M ﹤0.01% 2128
2017
Q1 		$3.83M Buy
428,034
+282,089
+193% +$3M ﹤0.01% 1849
2016
Q4 		$1.28M Sell
145,945
-17,373
-11% -$128K ﹤0.01% 2821
2016
Q3 		$1.1M Sell
163,318
-73,214
-31% -$283K ﹤0.01% 2871
2016
Q2 		$843K Buy
236,532
+10,503
+5% +$34.2K ﹤0.01% 3068
2016
Q1 		$667K Buy
226,029
+94,848
+72% +$284K ﹤0.01% 3029
2015
Q4 		$554K Sell
131,181
-857
-0.6% -$3.91K ﹤0.01% 3300
2015
Q3 		$602K Sell
132,038
-204,443
-61% -$1.21M ﹤0.01% 3266
2015
Q2 		$2.43M Buy
336,481
+141,580
+73% +$1.04M ﹤0.01% 2396
2015
Q1 		$1.44M Sell
194,901
-72,269
-27% -$514K ﹤0.01% 2686
2014
Q4 		$1.26M Buy
267,170
+181,330
+211% +$717K ﹤0.01% 2934
2014
Q3 		$306K Sell
85,840
-33,957
-28% -$134K ﹤0.01% 3928
2014
Q2 		$546K Sell
119,797
-26,097
-18% -$108K ﹤0.01% 3772
2014
Q1 		$686K Sell
145,894
-109,053
-43% -$548K ﹤0.01% 3470
2013
Q4 		$1.28M Buy
254,947
+147,117
+136% +$801K ﹤0.01% 3070
2013
Q3 		$671K Buy
107,830
+4,290
+4% +$25.5K ﹤0.01% 3293
2013
Q2 		$470K Buy
+103,540
New +$557K ﹤0.01% 3340

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Credit Suisse's ARRY Position: Q3 2019 in Review

Credit Suisse sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,479,960 shares — an estimated $115M sold.

Credit Suisse first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $115M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Credit Suisse reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 2,479,960 Array Biopharma Inc shares in Q3 2019, an estimated $115M.
  • Credit Suisse first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Credit Suisse's Array Biopharma Inc position peaked at $115M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.